This grant funds initiatives aimed at reducing opioid-related overdose deaths by increasing access to FDA-approved medications for opioid use disorder and supporting a continuum of prevention, harm reduction, treatment, and recovery services. It targets diverse populations including women, youth, veterans, and adults, and aligns with strategic goals to delay substance use initiation and improve timely access to evidence-based treatment.
Eligible applicants include women, pregnant women, veterans, children and adolescents, transition-age youth and young adults, adults, and individuals with opioid use disorder.
